Business
PharmAust (ASX:PAA) share price soars 7% on positive update
The PharmAust Limited (ASX: PAA) share price is shooting upwards following an update on its antiviral program. In late afternoon trade, the PharmAust share price is trading for 11 cents apiece, up 7.1%.
What did PharmAust announce?
Investors are pushing PharmAust shares higher after taking in the company’s progress on antiviral activity against COVID-19.
In its announcement, PharmAust provided an update on its lead drug candidates as antiviral therapeutics. These include monepantel (MPL) and also monepantel sulfone (MPLS).
The company stated that data from extensive testing at Leiden University Medical Center (LUMC) has demonstrated antiviral…
-
Noosa News18 hours agoPrincess Anne is coming to Australia. Here’s what we know of her plans
-
General7 hours agoCommunity devastated after freight train kills one-year-old girl near Narrabri
-
General5 hours agoPolice allowed neo-Nazi protest outside NSW parliament
-
General23 hours agoPolish woman found guilty of harassing Maddie McCann’s parents, but acquitted for stalking